Accordingly, AHR agonists are capable of ameliorating colitis in mice (Cervantes-Barragan et al., 2017; Aoki et al., 2018), while AHR antagonists enhanced the severity of colitis (Monteleone et al., 2011). The gene discussed is AHR; the disease is colitis.